Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | methyltransferase-related | 0.0324 | 0.0494 | 0.0294 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0698 | 0.2482 | 0.4903 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.1607 | 0.7323 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.1075 | 0.4493 | 0.4377 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.1142 | 0.4848 | 1 |
Brugia malayi | Methyltransferase-like protein 4 | 0.0324 | 0.0494 | 0.0387 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.027 | 0.0206 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.027 | 0.0206 | 0.5 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.1607 | 0.7323 | 1 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.1075 | 0.4493 | 0.4431 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.1142 | 0.4848 | 0.6337 |
Schistosoma mansoni | glutaminase | 0.211 | 1 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0711 | 0.2554 | 0.2941 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.2038 | 0.9617 | 0.9613 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.1042 | 0.4317 | 0.5799 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.1005 | 0.4117 | 0.4117 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0896 | 0.3539 | 0.4711 |
Giardia lamblia | Methyltransferase like 2 | 0.0324 | 0.0494 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.1005 | 0.4117 | 0.4051 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.0373 | 0.0753 | 0.0558 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.1142 | 0.4848 | 0.6541 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.1005 | 0.4117 | 0.5519 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0711 | 0.2554 | 0.2397 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.1075 | 0.4493 | 0.581 |
Loa Loa (eye worm) | glutaminase | 0.211 | 1 | 1 |
Plasmodium vivax | 3-oxoacyl-[acyl-carrier-protein] synthase i/ii, putative | 0.027 | 0.0206 | 0.5 |
Echinococcus multilocularis | adam 17 protease | 0.0373 | 0.0753 | 0.9418 |
Loa Loa (eye worm) | glutaminase 2 | 0.211 | 1 | 1 |
Onchocerca volvulus | 0.1872 | 0.873 | 0.9609 | |
Mycobacterium ulcerans | polyketide synthase | 0.1142 | 0.4848 | 0.474 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0338 | 0.0567 | 0.0558 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0896 | 0.3539 | 0.4398 |
Chlamydia trachomatis | 3-oxoacyl-ACP synthase | 0.027 | 0.0206 | 0.5 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.1142 | 0.4848 | 0.6541 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0379 | 0.0786 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.1042 | 0.4317 | 0.5799 |
Toxoplasma gondii | AMP-binding enzyme domain-containing protein | 0.0543 | 0.1662 | 0.3136 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.1075 | 0.4493 | 0.581 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0324 | 0.0494 | 0.0455 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0435 | 0.1084 | 0.128 |
Onchocerca volvulus | 0.1005 | 0.4117 | 0.4531 | |
Mycobacterium ulcerans | thioesterase TesA | 0.0896 | 0.3539 | 0.3403 |
Mycobacterium tuberculosis | Conserved protein | 0.0324 | 0.0494 | 0.0455 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.027 | 0.0206 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0611 | 0.2023 | 0.2593 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.037 | 0.0737 | 0.0795 |
Trichomonas vaginalis | glutaminase, putative | 0.211 | 1 | 1 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0338 | 0.0567 | 0.0369 |
Mycobacterium ulcerans | polyketide synthase MbtD | 0.0331 | 0.0529 | 0.033 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.1142 | 0.4848 | 0.6337 |
Loa Loa (eye worm) | matrixin family protein | 0.0252 | 0.0111 | 0.0111 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.1075 | 0.4493 | 0.6044 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.1075 | 0.4493 | 0.6044 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.1142 | 0.4848 | 0.474 |
Trypanosoma brucei | beta-ketoacyl-ACP synthase | 0.027 | 0.0206 | 0.5 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.0292 | 0.0325 | 0.2049 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.027 | 0.0206 | 0.0096 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0879 | 0.345 | 0.4587 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.1075 | 0.4493 | 0.4377 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0379 | 0.0786 | 0.6658 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.1142 | 0.4848 | 0.474 |
Mycobacterium ulcerans | polyketide synthase | 0.1075 | 0.4493 | 0.4377 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.1938 | 0.9086 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0865 | 0.3374 | 0.3235 |
Mycobacterium ulcerans | thioesterase | 0.0896 | 0.3539 | 0.3403 |
Leishmania major | hypothetical protein, conserved | 0.0324 | 0.0494 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0711 | 0.2554 | 0.2397 |
Echinococcus granulosus | adam 17 protease | 0.0434 | 0.1078 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0865 | 0.3374 | 0.4155 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0865 | 0.3374 | 0.3235 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.1142 | 0.4848 | 0.6541 |
Loa Loa (eye worm) | fatty acid synthase | 0.1061 | 0.4416 | 0.4416 |
Mycobacterium ulcerans | glutaminase | 0.211 | 1 | 1 |
Mycobacterium tuberculosis | Polyketide synthetase MbtD (polyketide synthase) | 0.0331 | 0.0529 | 0.0505 |
Brugia malayi | AMP-binding enzyme family protein | 0.0331 | 0.0529 | 0.0423 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0772 | 0.2881 | 0.3791 |
Loa Loa (eye worm) | beta-ketoacyl synthase domain-containing protein | 0.027 | 0.0206 | 0.0206 |
Loa Loa (eye worm) | hypothetical protein | 0.0602 | 0.1976 | 0.1976 |
Plasmodium falciparum | 3-oxoacyl-acyl-carrier protein synthase I/II | 0.027 | 0.0206 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.1075 | 0.4493 | 0.4377 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.1142 | 0.4848 | 0.6337 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.1075 | 0.4493 | 0.6044 |
Loa Loa (eye worm) | hypothetical protein | 0.1806 | 0.8384 | 0.8384 |
Loa Loa (eye worm) | hypothetical protein | 0.0841 | 0.3248 | 0.3248 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.1075 | 0.4493 | 0.4377 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.0292 | 0.0325 | 0.1364 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.1607 | 0.7323 | 0.7267 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0765 | 0.2843 | 0.5682 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.1607 | 0.7323 | 1 |
Loa Loa (eye worm) | acyl carrier protein | 0.0494 | 0.1401 | 0.1401 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.296 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.823 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.751 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.69 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.685 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.611 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.558 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.442 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.442 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.